MedPath

CIPRALEX MELTZ

CIPRALEX MELTZ

Discontinued
DIN Number

02391449

Drug Class

Human

Market Date

Oct 4, 2012

Company
HC

Lundbeck Canada Inc

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02391449
AIG Number0150435002
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
N06AB10 ESCITALOPRAM
Product Specifications
Dosage FormTablet (Orally Disintegrating)
Route of AdministrationOral
AHFS Classification28:16.04.20
Health Canada Classification

ACTIVE INGREDIENTS (1)

ESCITALOPRAMActive
Strength: 10 MG
Monograph: ESCITALOPRAM

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.